CDI Laboratory Develops Promising New Antibiotic for Resistant Gonorrhea
/PRNewswire/ -- A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great...
Stay updated with breaking news from David Perlin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great...
A new publication in a major journal by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) could hold the key to better modulating the human immune system to fight cancer and produce vaccines of the future.
The inaugural Innovation kNowledge eXchange of 2022 (INX22) focused on developing groundbreaking solutions to some of the world’s top challenges.
Experts are joining forces to form the Metropolitan AntiViral Drug Accelerator to research and produce treatments for viral threats.
The partnership between virologists and drugmakers aims to develop drugs that can be taken by mouth without requiring admission to a hospital.